Cite Filings / CTMX / 0001564590-17-024265

Feed Companies Filings Check

Sign in

8-K

Current Report

CytomX Therapeutics, Inc. Filed 2017-11-28 Acc 0001564590-17-024265

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , ctmx-8k_20171128.htm

Around this filing

2017-12-05 4 Chief Financial Officer sold 2,500 shares at $20.58 ($51,450)
2017-12-05 4 President and CEO sold 14,340 shares at $20.60 ($295,404)
2017-12-04 8-K Executive or director change
2017-11-28 8-K Other events
2017-11-07 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ctmx-8k_20171128.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…